10x Genomics, Inc. (LON:0A88)

10x Genomics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 10, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,161	1,389	5,193	3,462	12,289	11,160
Market Cap Growth	-43.51%	-73.26%	50.02%	-71.83%	10.11%	101.57%
Enterprise Value	895	1,139	4,990	3,166	11,905	10,642
Last Close Price	9.41	11.43	43.86	29.90	112.31	-
PS Ratio	2.47	2.85	10.69	8.08	33.92	50.99
PB Ratio	2.06	2.45	8.93	5.18	20.35	20.62
P/TBV Ratio	2.11	2.52	9.19	5.36	21.13	21.26
P/OCF Ratio	23.76	260.86	-	-	-	-
EV/Sales Ratio	1.88	2.34	10.27	7.39	32.86	48.62
Debt / Equity Ratio	0.11	0.12	0.13	0.12	0.10	0.09
Asset Turnover	0.68	0.65	0.62	0.50	0.50	0.39
Inventory Turnover	2.50	2.50	2.70	1.70	1.65	2.59
Quick Ratio	5.05	4.09	3.96	4.08	6.10	6.05
Current Ratio	5.84	4.97	4.69	4.85	6.77	6.56
Return on Equity (ROE)	-11.30%	-25.17%	-32.98%	-20.45%	-7.48%	-93.64%
Return on Assets (ROA)	-9.45%	-12.77%	-12.52%	-9.99%	-3.40%	-6.95%
Return on Capital (ROIC)	-10.79%	-14.77%	-14.37%	-11.37%	-3.89%	-8.52%
Earnings Yield	-5.32%	-10.51%	-3.86%	-3.98%	-0.35%	-3.56%
FCF Yield	3.58%	-0.33%	-0.96%	-3.96%	-0.74%	-1.67%
Buyback Yield / Dilution	-2.95%	-2.80%	-2.90%	-3.18%	-9.09%	-158.76%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.